skip to main content

News Archive

Date: 05/23/2018
ANN ARBOR, Michigan — With the recently announced FDA approval of Kymriah to treat adults with lymphoma, the University of Michigan Rogel Cancer Center is the first center in Michigan to offer all currently available CAR T-cell therapies.
Date: 05/21/2018
Researchers from the University of Michigan Rogel Cancer Center will attend the American Society for Clinical Oncology (ASCO) Annual meeting from Friday, June 1 through Tuesday, June 5. Many of them plan to participate in poster sessions. A schedule is available to make it easy to know who is presenting, when, where and on what topic.
Date: 05/09/2018
Although it is rare, knowledge of this risk is important both for the ophthalmologists who treat it and for the oncologists prescribing the anti-cancer treatment, say Michigan Medicine researchers. The cases of three recent patients, published in JAMA Ophthalmology, highlight the issue. Patients receiving immune checkpoint inhibitors developed uveal effusions and eye inflammation that affected their vision.
Date: 05/09/2018
Researchers from the University of Michigan Rogel Cancer Center will attend the American Society for Cancer Oncology (ASCO) Annual meeting from Friday, June 1 through Tuesday, June 5. Many of them plan to participate in poster sessions. A schedule is available to make it easy to know who is presenting, when, where and on what topic.
Date: 04/30/2018
As many as one in three women treated for breast cancer undergo unnecessary procedures, which is why it's important to find new ways to diagnose the disease. Research in mice finds a special kind of pill could do a better job distinguishing between benign and aggressive tumors.
Date: 04/11/2018
Richard and Susan Rogel are on a mission to boost innovative cancer research and develop the next generation of cancer pioneers -- and they are committing $150 million to the University of Michigan Comprehensive Cancer Center to realize that vision.
Date: 04/10/2018
Researchers from the University of Michigan Rogel Cancer Center will attend the American Assocation for Cancer Research Annual meeting from Sunday, April 14 through Wednesday, April 18. Many of them plan to participate in poster sessions. A schedule is available to make it easy to know who is presenting, when, where and on what topic.
Date: 03/28/2018
As new genes are linked to breast cancer occurring in families, and as genetic testing becomes more important in directing treatment for newly diagnosed patients, a substantial number of those at the highest risk are not getting tested.
Date: 03/27/2018
Diane Harper, M.D., MPH, M.S., professor of family medicine at Michigan Medicine, has been named physician director for Community Outreach, Engagement and Health Disparities at the University of Michigan Rogel Cancer Center. She will lead the establishment of a community outreach engagement committee to build relationships with the community and seek input from community leaders.
Date: 02/20/2018
When PGE2 is out of balance and the body makes too much, it can lead to inflammation and to conditions such as cancer and heart disease. Other fatty acids, particularly omega-3 fatty acids, reduce the amount of omega-6 fatty acids available in a cell. This is a key system that controls how much PGE2 the cell makes

Pages